. 2024 Oct 31;60(11):1781. doi: 10.3390/medicina60111781
© 2024 by the authors.
Published by MDPI on behalf of the Lithuanian University of Health Sciences. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Figure 1.
Summarizes pathophysiology of increased CV risk in MASLD.